Ascidian Therapeutics Raises $40 Million in Series A Extension Financing from Apple Tree Partners and Appoints Michael Ehlers as Interim CEO ...Middle East

Funds from ATP will support the progress of Ascidian's lead program in ABCA4 retinopathies, including Stargardt disease, and advance key pipeline programs in CNS and neuromuscular diseases Ascidian anticipates filing an IND and initiating a first-in-patient trial in ABCA4 retinopathy in...

Hence then, the article about ascidian therapeutics raises 40 million in series a extension financing from apple tree partners and appoints michael ehlers as interim ceo was published today ( Wednesday 08/11/2023 - 08:52 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Ascidian Therapeutics Raises $40 Million in Series A Extension Financing from Apple Tree Partners and Appoints Michael Ehlers as Interim CEO )

Also on site :

• Kyle Busch’s Car Unloaded at North Carolina Racetrack After Shocking Death, on Video
• Zelensky dismisses ‘associate’ EU membership as ‘unfair’ – Reuters
• Trump announces Iran deal ‘finalization’